AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 3.03 |
Market Cap | 151.14M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.83 |
PE Ratio (ttm) | -1.72 |
Forward PE | n/a |
Analyst | Buy |
Ask | 3.6 |
Volume | 829,593 |
Avg. Volume (20D) | 1,485,240 |
Open | 3.23 |
Previous Close | 3.20 |
Day's Range | 3.13 - 3.35 |
52-Week Range | 1.38 - 4.50 |
Beta | undefined |
About CKPT
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-...
Analyst Forecast
According to 3 analyst ratings, the average rating for CKPT stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 186.62% from the latest price.
3 weeks ago · seekingalpha.com
Checkpoint Therapeutics: Updating My Strategy After Unloxcyt's ApprovalCheckpoint Therapeutics, Inc. received FDA approval for Unloxcyt, the first PD-L1 drug for advanced cSCC, with strong clinical results and a market-disruptive pricing strategy. Despite mixed investor ...
2 months ago · seekingalpha.com
Checkpoint Therapeutics: Preparing For Cosibelimab's Upcoming PDUFA DateCheckpoint Therapeutics, Inc.'s cosibelimab shows promising efficacy and safety in treating cSCC, with a high tumor occupancy rate and strong clinical data. The upcoming PDUFA date on December 28th is...